Literature DB >> 20435346

The influence of poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide on fibrin polymerization, cross-linking and clot structure.

Benjamin F L Lai1, Yuquan Zou, Donald E Brooks, Jayachandran N Kizhakkedathu.   

Abstract

Poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide (PDMDOMA) is a neutral synthetic water-soluble polymer. In this report, we evaluated the influence of PDMDOMA on blood hemostasis by studying the fibrin polymerization process, the three-dimensional clot structure, and the mechanical properties and fibrinolysis. PDMDOMA altered the normal fibrin polymerization by changing the rate of protofibril aggregation and resulting in a 5-fold increase in the overall turbidity. Fibrin clots formed in presence of PDMDOMA exhibited thinner fibers with less branching which resulted in a more porous and heterogeneous clot structure in scanning electron micrographs. The overall strength and rigidity of the whole blood clot also decreased up to 10-fold. When a combination of plasminogen and tissue-plasminogen activators were included in clotting reactions, fibrin clots formed in the presence of PDMDOMA exhibited highly shortened clot lysis times and was supported by the enhanced clot lysis measured by thromboelastography in whole blood. Further evidence of the altered clot structure and clot cross-linking was obtained from the significant decrease in d-dimer levels measured from degraded plasma clot. Thus, PDMDOMA may play an important role as an antithrombotic agent useful in prophylactic treatments for thrombosis by modulating fibrin clot structure to enhance fibrinolysis. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435346     DOI: 10.1016/j.biomaterials.2010.03.076

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  5 in total

1.  Blood Compatibility of Hydrophilic Polyphosphoesters.

Authors:  Chiara Pelosi; Iren Constantinescu; Helena H Son; Maria Rosaria Tinè; Jayachandran N Kizhakkedathu; Frederik R Wurm
Journal:  ACS Appl Bio Mater       Date:  2022-02-24

Review 2.  Polymeric drugs: Advances in the development of pharmacologically active polymers.

Authors:  Jing Li; Fei Yu; Yi Chen; David Oupický
Journal:  J Control Release       Date:  2015-09-26       Impact factor: 9.776

3.  Influence of Interleukin-1 Beta on Platelet-Poor Plasma Clot Formation: A Potential Impact on Early Bone Healing.

Authors:  Xin Wang; Yan Luo; Paul P Masci; Ross Crawford; Yin Xiao
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

4.  Genipin modified lyophilized platelet-rich fibrin scaffold for sustained release of growth factors to promote bone regeneration.

Authors:  Xiaoyao Liu; Mingjing Yin; Ying Li; Jianqun Wang; Junlong Da; Zhongshuang Liu; Kai Zhang; Lixue Liu; Wenxuan Zhang; Peijun Wang; Han Jin; Bin Zhang
Journal:  Front Physiol       Date:  2022-09-30       Impact factor: 4.755

5.  Adenosine diphosphate-decorated chitosan nanoparticles shorten blood clotting times, influencing the structures and varying the mechanical properties of the clots.

Authors:  Tze-Wen Chung; Pei-Yi Lin; Shoei-Shen Wang; Yen-Fung Chen
Journal:  Int J Nanomedicine       Date:  2014-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.